Yasmyn Ellaynah Winstanley

Dr. Yasmyn Ellaynah Winstanley

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2022 in Science Advances
Verified
Journal Article
Open access
TUTakashi Umehara
Takashi Umehara
YWYasmyn Ellaynah Winstanley
Yasmyn Ellaynah Winstanley
EAEryk Andreas
Eryk Andreas
AMAtsushi Morimoto
Atsushi Morimoto
EWElisha J. Williams
Elisha J. Williams
RRRebecca Robker
Rebecca Robker
The female ovary contains a finite number of oocytes, and their release at ovulation becomes sporadic and disordered with aging and with obesity, leading to loss of fertility. Understanding the molecular defects underpinning this pathology is essential as age of childbearing and obesity rates increase globally. We identify that fibrosis within the ovarian stromal compartment is an underlying mechanism responsible for impaired oocyte release, which is initiated by mitochondrial dysfunction leading to diminished bioenergetics, oxidative damage, inflammation, and collagen deposition. Furthermore, antifibrosis drugs (pirfenidone and BGP-15) eliminate fibrotic collagen and restore ovulation in reproductively old and obese mice, in association with dampened M2 macrophage polarization and up-regulated MMP13 protease. This is the first evidence that ovarian fibrosis is reversible and indicates that drugs targeting mitochondrial metabolism may be a viable therapeutic strategy for women with metabolic disorders or advancing age to maintain ovarian function and extend fertility.

16 July 2024 in Human Reproduction
Verified
Journal Article
Open access
PDF file
AMAtsushi Morimoto
Atsushi Morimoto
RRRyan D Rose
Ryan D Rose
KSKirsten M Smith
Kirsten M Smith
DDDoan T Dinh
Doan T Dinh
TUTakashi Umehara
Takashi Umehara
RRRebecca Robker
Rebecca Robker
Is oocyte developmental competence associated with changes in granulosa cell (GC) metabolism? GC metabolism is regulated by the LH surge, altered by obesity and reproductive aging, and, in women, specific metabolic profiles are associated with failed fertilization versus increased blastocyst development. The cellular environment in which an oocyte matures is critical to its future developmental competence. Metabolism is emerging as a potentially important factor; however, relative energy production profiles between GCs and cumulus cells and their use of differential substrates under normal in vivo ovulatory conditions are not well understood. This study identified metabolic and substrate utilization profiles within ovarian cells in response to the LH surge, using mouse models and GCs of women undergoing gonadotropin-induced oocyte aspiration followed by IVF/ICSI. To comprehensively assess follicular energy metabolism, we used real-time metabolic analysis (Seahorse XFe96) to map energy metabolism dynamics (mitochondrial respiration, glycolysis, and fatty acid oxidation) in mouse GCs and cumulus–oocyte complexes (COCs) across a detailed time course in the lead up to ovulation. In parallel, the metabolic profile of GCs was measured in a cohort of 85 women undergoing IVF/ICSI (n = 21 with normal ovarian function; n = 64 with ovarian infertility) and correlated with clinical parameters and cycle outcomes. Our study reveals dynamic changes in GC energy metabolism in response to ovulatory LH, with mitochondrial respiration and glycolysis differentially affected by obesity versus aging, in both mice and women. High respiration in GCs is associated with failed fertilization (P < 0.05) in a subset of women, while glycolytic reserve and mitochondrial ATP production are correlated with on-time development at Day 3 (P < 0.05) and blastocyst formation (P < 0.01) respectively. These data provide new insights into the cellular mechanisms of infertility, by uncovering significant associations between metabolism within the ovarian follicle and oocyte developmental competence. A larger prospective study is needed before the metabolic markers that were positively and negatively associated with oocyte quality can be used clinically to predict embryo outcomes. This study offers new insights into the importance of GC metabolism for subsequent embryonic development and highlights the potential for therapeutic strategies focused on optimizing mitochondrial metabolism to support embryonic development. National Health and Medical Research Council (Australia). The authors have no competing interests. N/A.

14 March 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
YWYasmyn Ellaynah Winstanley
Yasmyn Ellaynah Winstanley
Ryan David RoseRyan David Rose
Ryan David Rose
ASAlexander P. Sobinoff
Alexander P. Sobinoff
LWLinda L. Wu
Linda L. Wu
DADeepak Adhikari
Deepak Adhikari
RRRebecca Robker
Rebecca Robker
The initial setting of telomere length during early life in each individual has a major influence on lifetime risk of aging-associated diseases; however there is limited knowledge of biological signals that regulate inheritance of telomere length, and whether it is modifiable is not known. We now show that when mitochondrial activity is disrupted in mouse zygotes, via exposure to 20% O2 or rotenone, telomere elongation between the 8-cell and blastocyst stage is impaired, with shorter telomeres apparent in the pluripotent Inner Cell Mass (ICM) and persisting after organogenesis. Identical defects of elevated mtROS in zygotes followed by impaired telomere elongation, occurred with maternal obesity or advanced age. We further demonstrate that telomere elongation during ICM formation is controlled by mitochondrial-nuclear communication at fertilization. Using mitochondrially-targeted therapeutics (BGP-15, MitoQ, SS-31, metformin) we demonstrate that it is possible to modulate the preimplantation telomere resetting process and restore deficiencies in neonatal telomere length.

13 December 2024 in Nature Aging
Verified
Journal Article
Closed access
PDF file
YWYasmyn Ellaynah Winstanley
Yasmyn Ellaynah Winstanley
JSJennifer S. Stables
Jennifer S. Stables
MGMacarena Gonzalez
Macarena Gonzalez
TUTakashi Umehara
Takashi Umehara
RNRobert J. Norman
Robert J. Norman
RRRebecca Robker
Rebecca Robker

16 March 2024 in Genes
Verified
Journal Article
Open access
PDF file
YWYasmyn Ellaynah Winstanley
Yasmyn Ellaynah Winstanley
JLJun Liu
Jun Liu
DADeepak Adhikari
Deepak Adhikari
MGMacarena Gonzalez
Macarena Gonzalez
DRDarryl L. Russell
Darryl L. Russell
RRRebecca Robker
Rebecca Robker
Mitochondria undergo a myriad of changes during pre-implantation embryo development, including shifts in activity levels and mitochondrial DNA (mtDNA) replication. However, how these distinct aspects of mitochondrial function are linked and their responsiveness to diverse stressors is not well understood. Here, we show that mtDNA content increased between 8-cell embryos and the blastocyst stage, with similar copy numbers per cell in the inner cell mass (ICM) and trophectoderm (TE). In contrast, mitochondrial membrane potential (MMP) was higher in TE than ICM. Culture in ambient oxygen (20% O2) altered both aspects of mitochondrial function: the mtDNA copy number was upregulated in ICM, while MMP was diminished in TE. Embryos cultured in 20% O2 also exhibited delayed development kinetics, impaired implantation, and reduced mtDNA levels in E18 fetal liver. A model of oocyte mitochondrial stress using rotenone showed only a modest effect on on-time development and did not alter the mtDNA copy number in ICM; however, following embryo transfer, mtDNA was higher in the fetal heart. Lastly, endogenous mitochondrial dysfunction, induced by maternal age and obesity, altered the blastocyst mtDNA copy number, but not within the ICM. These results demonstrate that mitochondrial activity and mtDNA content exhibit cell-specific changes and are differentially responsive to diverse types of oxidative stress during pre-implantation embryogenesis.

14 February 2026 in Environmental Research
Verified
Journal Article
Open access
YWYasmyn Ellaynah Winstanley
Yasmyn Ellaynah Winstanley
DHDonna L. Holland
Donna L. Holland
NMNicole O. McPherson
Nicole O. McPherson
EBErin Barrera
Erin Barrera
HCHaley S. Connaughton
Haley S. Connaughton
RRRebecca Robker
Rebecca Robker
Perfluoroalkyl and polyfluoroalkyl substances (PFAS), synthetic and resistant to degradation, are present at trace levels in municipal drinking water. PFAS exposure is associated with female infertility and developmental anomalies, yet how these compounds influence ovarian function and embryogenesis is not understood. Thus, the impact of exposure to PFAS via drinking water on oocyte viability and embryo development was examined. The local tap water was found to contain ∼3 ng/L PFAS, primarily PFOS, PFOA, and PFHxS. Female mice were then given purified water containing 5 ng/L or 50 ng/L of these same three PFAS compounds or drinking fountain (tap) water for 4 weeks or 6 months. Ovulation, oocyte quality, embryo development and fetal weight were analyzed across three generations. Embryos from PFAS-exposed females (5 ng/L or 50 ng/L PFAS or tap water) exhibited impaired mitochondrial function, DNA damage and fewer cells, and reduced fetal weight. Embryo phenotypes were similar whether females were PFAS-exposed for 4 weeks, 6 months or just the first 4 weeks of the 6 months. Offspring drank purified water, yet fertility analysis showed similar embryonic and neonatal phenotypes in the F1 'daughters' of the PFAS-exposed females, and in the embryos of F2 females ('granddaughters' of PFAS-exposed females). To determine causality and whether defects are reversible, embryos were treated mitochondria-modulating compounds, with responses indicating that PFAS exposure irreversibly impairs key aspects of mitochondrial function. These findings identify cellular targets and mechanisms by which PFAS disrupt female fertility; reveal that PFAS cause intergenerational changes in mammalian embryos; and have important implications for water quality policies.